Literature DB >> 3675308

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.

J R McNamara1, H Campos, J M Ordovas, J Peterson, P W Wilson, E J Schaefer.   

Abstract

The presence of low molecular weight low density lipoprotein (LDL) particles in plasma has been associated with premature coronary artery disease. In this study we have examined factors affecting LDL subfraction distribution as determined by 2% to 16% polyacrylamide-agarose gradient gel electrophoresis of whole plasma in a normal, primarily middle-aged, population of adult male and female participants (n = 280, ages 25 to 75 years) in the Framingham Offspring Study. Seven major LDL bands (LDL-1 to LDL-7) were observed in different individuals, with most subjects having either one or two major bands. The presence of low molecular weight LDL (LDL-4 to LDL-7) in plasma as the predominant LDL type was significantly more common in men than in women (43.5% versus 14.8%, p less than 0.001). The presence of low molecular weight LDL was correlated (p less than 0.01) with increased age, plasma triglyceride, total cholesterol, very low density lipoprotein (VLDL) cholesterol, LDL cholesterol (in women only), and apolipoprotein (apo) B concentrations, as well as with decreased high density lipoprotein (HDL) cholesterol and apo A-I levels. Approximately 69% of the variability in LDL subfractions could be accounted for by alterations in plasma triglyceride and HDL cholesterol levels. These data are consistent with the concept that LDL subfraction distribution is influenced by gender and plasma lipoprotein levels and can be determined readily by the use of whole plasma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675308     DOI: 10.1161/01.atv.7.5.483

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  36 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.

Authors:  J de Graaf; D W Swinkels; A F de Haan; P N Demacker; A F Stalenhoef
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 3.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

4.  Profiles by sex of brain MRI and cognitive function in the framingham offspring study.

Authors:  Mark Albert; Joseph Massaro; Charles DeCarli; Alexa Beiser; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

5.  Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.

Authors:  Jean-Claude Ansquer; Christophe Corda; Karine Le Malicot; Valerie Jessent
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

6.  Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women.

Authors:  R R McLean; S L Booth; D P Kiel; K E Broe; D R Gagnon; K L Tucker; L A Cupples; M T Hannan
Journal:  Osteoporos Int       Date:  2006-01-06       Impact factor: 4.507

7.  Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women.

Authors:  Mahdi Garelnabi; Emir Veledar; Jerome Abramson; Jill White-Welkley; Nalini Santanam; William Weintraub; Sampath Parthasarathy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.

Authors:  Masumi Ai; Seiko Otokozawa; Bela F Asztalos; Yasuki Ito; Katsuyuki Nakajima; Charles C White; L Adrienne Cupples; Peter W Wilson; Ernst J Schaefer
Journal:  Clin Chem       Date:  2010-04-29       Impact factor: 8.327

9.  Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

Authors: 
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

10.  Lipoprotein lipase activity in patients with combined hyperlipidaemia.

Authors:  M Seed; F Mailly; D Vallance; E Doherty; A Winder; P Talmud; S E Humphries
Journal:  Clin Investig       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.